U.S.  Implements New Export Controls to Address National Security Risks Related to Biotechnology
| | | | | | | | | | | | |

U.S. Implements New Export Controls to Address National Security Risks Related to Biotechnology

On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…

Scripps Research scientists identified mutation that could facilitate H5N1 “bird flu” virus infection and potential transmission in humans
| | | | | | |

Scripps Research scientists identified mutation that could facilitate H5N1 “bird flu” virus infection and potential transmission in humans

On Dec. 5, 2024, a study led by scientists at Scripps Research reveals that a single mutation in…

Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year
| | | | | | |

Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from stroke each year

On Sept. 18, 2024, a study published in The Lancel reported that here has been a rapid rise…

Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
| | | |

Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma

On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…